<SEC-DOCUMENT>0001493152-20-000935.txt : 20200225
<SEC-HEADER>0001493152-20-000935.hdr.sgml : 20200225
<ACCEPTANCE-DATETIME>20200122182158
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001493152-20-000935
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20200122

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Protagenic Therapeutics, Inc.\new
		CENTRAL INDEX KEY:			0001022899
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-BUSINESS SERVICES, NEC [7389]
		IRS NUMBER:				061390025
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		149 FIFTH AVENUE
		STREET 2:		SUITE 500
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10010
		BUSINESS PHONE:		(212) 994-8200

	MAIL ADDRESS:	
		STREET 1:		149 FIFTH AVENUE
		STREET 2:		SUITE 500
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10010

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Atrinsic, Inc.
		DATE OF NAME CHANGE:	20090630

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NEW MOTION, INC.
		DATE OF NAME CHANGE:	20070504

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MPLC, Inc.
		DATE OF NAME CHANGE:	20050608
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><IMG SRC="logo_001.jpg" ALT="" STYLE="height: 83; width: 240"></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">149
Fifth Ave, Suite 500</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, NY 10010</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
22, 2020</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>VIA
EDGAR TRANSMISSION</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anthony
Watson</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Division
of Corporation Finance</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office
of Trade &amp; Services</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
Securities and Exchange Commission</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Division
of Corporation Finance</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Washington,
D.C. 20549</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 1.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RE:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Protagenic
    Therapeutics, Inc.</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form
    10-K for the Fiscal Year Ended December 31, 2018</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Filed
    March 29, 2019</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>File
    No. 000-51353</U></B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dear
Mr. Watson:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
am the Chief Financial Officer of Protagenic Therapeutics, Inc. (the &ldquo;<U>Company</U>&rdquo;) and am writing on behalf of
the Company in response to the letter from the Staff of the Division of Corporation Finance (the &ldquo;<U>Staff</U>&rdquo;),
of the U.S. Securities and Exchange Commission, dated January 6, 2020 (the &ldquo;<U>Comment Letter</U>&rdquo;) relating to the
above-referenced Form 10-K for the Fiscal Year Ended December 31, 2018 (the &ldquo;<U>Form 10-K</U>&rdquo;). Set forth below is
the Company&rsquo;s response to the comment raised in the Comment Letter. For the convenience of the Staff, the comments in the
Comment Letter are reprinted in bold and is followed by the Company&rsquo;s response.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Correspondence
filed December 23, 2019</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Note
5 Derivative Liabilities, page F-14</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Your
analysis of why the warrants are properly classified as liabilities is not sufficient or comprehensive enough. Please provide
us with an analysis of the conditions listed in ASC 815-40-25 through ASC 815-40-43, or tell us why the warrants should be classified
as liabilities citing specific guidance in ASC 815.&rdquo;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Response:
Under ASC 815 a warrant must meet all of the requirement laid out in the guidance to be classified as equity. If the terms of
the warrants fail to meet any of the requirement then they must be classified as a liability.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">One
of the conditions set forth in ASC 815 is that the warrant <B>must place an explicit limit on the number of shares that will be
issued when the warrant is exercised</B>. The Company warrants in question do not place an explicit limit on the number of shares
that will be issued when the warrant is exercised. Since they do not satisfy this requirement, the Company concluded that the
warrants in question should be classified as liabilities under ASC 815.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
815 sets forth other requirements as well. Per ASC 815, to be classified as equity, a warrant:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Must
                                         place an explicit limit on the number of shares that will be issued when the warrant
                                         is exercised (ours do not).</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Is
                                         required to be physically settled in shares or net share settled or the acquirer has
                                         a choice of net cash settlement or settlement in shares (either net share settlement
                                         or physical settlement).</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Must
                                         require net cash settlement only in specific circumstances in which holders of shares
                                         underlying the contract also would receive cash in exchange for their shares if an event
                                         could trigger net cash settlement that is outside the issuer&rsquo;s control.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Must
                                         permit the acquirer to settle in unregistered shares.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Be
                                         owned by an acquirer who has sufficient authorized and unissued shares to settle the
                                         contract. In making that determination, the acquirer must consider all other commitments
                                         or potentially dilutive instruments (e.g., options, warrants, convertible arrangements)
                                         that may require the issuance of shares during the maximum period the arrangement could
                                         remain outstanding.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Be
                                         free of required cash payments to the seller in the event the acquirer fails to make
                                         timely filings with the SEC.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Have
                                         no cash-settled top-off or make-whole provisions.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Have
                                         no provisions in the arrangement that indicate that the seller has rights that rank higher
                                         than those of a holder of the shares underlying the contract.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Have
                                         no requirement in the contract to post collateral at any point or for any reason</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">None
of these other conditions are applicable to the Company&rsquo;s warrants. However, since the Company&rsquo;s warrants do not meet
one of the requirements of ASC 415, the Company concluded that they must be classified as liabilities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Should
the Staff have additional questions or comments regarding the foregoing or the Form 10-K, please contact me at (310) 766-6223.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 50%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very
    truly yours,</FONT></TD>
    <TD STYLE="width: 50%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alexander
    K. Arrow, MD</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.35in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cc:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kenneth
    S. Goodwin (ksg@msf-law.com)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>logo_001.jpg
<TEXT>
begin 644 logo_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !4 /,# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH *0$$D C(KRKQ;XNNK^^EL[*=H;.)BF8S@RD=23Z>U<K%<3V\HEAFDCD!R
M'1B#^=>=4S&,9<L5<YI8E)V2/H"BN/\ !'BB76(Y+&]8-=PKN63_ )Z+TY]Q
MQ^==A7;2JQJP4XF\)*2N@HHHK0H**** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHJ.::*WA:::18XT&6=C@ 4 254U2^BTW2
MKN^F;;'!"TC'/H,UG6OBK3M0N9;;3O.O)HT+[8U"Y ('!8@=Q7D/Q,\;:SJ,
MC:)-IL^EV@(9HYOOS8Z$D<;<]AGD=:UPM/ZQ+W7H85:\81N>B6?@/0;^Q@O(
M9[MHYXUD5A(O((R/X:XSQ9H]MHFM?8[5I&C\I7S(03DY] /2JOPQ\;ZQ:%=#
M&F7.J6B\IY ^> $^IXV_4CZ]J[7Q)X5U3Q#KJ7<,26\)B529W&5(SGA<^M>?
MF67JDK4XZWZ=C#W:E.\%J8GP\ADD\3B1 =D<+ES]< ?K7K-8_A[P];>'K(PP
MDR2N<RRD8+'^@]JV*K"472I<LMSIHP<(V84445TFH4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !7F'Q$U>:;55TQ'(@@4,Z
M@_><C//T&/UKT^O*_B)IDMOK@OPI,%RH&[L& P1^0!KBS#F]CI\S#$7Y- ^&
MW_(QS_\ 7JW_ *$M=;X\\-V_B3PO=0M&#=0(TMM)CE7 SCZ'&#]?:O(U=D.4
M8J?4'%:N@6EYJVLV]I%)*5+!I"&.%0=2:Y,%CG0M&,;NYSPJ+E]FU>YV+Q1_
M#+X<?:+*UBFNHQ&9R_'FR,0"21SQGCZ5E?\ "Q_%5EIL&L:CX40Z5*JN)H)N
MBMT)ZXZ]P*W/BQ_R3N__ -^+_P!&+7$GQRFJ> +7PKH^E7UWJ,EFEJY\L;%P
M "1@DG]/6OIZ4/:0YY1NV]?0JI+DERIVLM#U_2-5M=;TFVU*R8M;W";E)&".
MQ!]P<C\*\]7X@>*M0US5=/T7P]:WBZ?.\;GS=K8#%0>2.3M/2NP\%:)-X=\(
MV&F7# SQ*6DP<@,S%B!],X_"O(M,\9GP9XO\53_V<UVMQ>NF1)L"$2.1DX/7
MG\C4T:492FHKFMM]Y=6HXJ/,[7W^X]+\&^.QXFO+O3+S3WT_5+09DA9L@@'!
MQP""#CCWK<\0^(+#PSI$FHZ@Y$:G:J+RTC'HJCUKD_ GAK4UU[4/%NL^1'<Z
MBG[J"!PZJC$')(XZ*N,$UD_%/%[XP\*:5<9^QRS N#T;<ZJ?T_G4^RIRK<L=
MNOW:V'[2<:7,]_ZL6$\=^-[^V_M'3O!X;3B-R[W)=U]1R"?P4UTW@SQQ9^+[
M>8+"UK?6_P#KK9SDCW!XR/PXKJ%4*H50 H& !VKR?3HUL?V@+Z*U&V.>$M*J
M],M&KG_QX _C1'DJQDE&S2NO^"#YZ;C>5[NQO^(_%/BS2+^]^Q^&$N=-MUWB
MZ:;&5"@L<9[<_E61I/Q!\8ZW:)=Z?X3BGMF8KYBS\9'7K7>>)O\ D5-8_P"O
M&;_T UR_P?\ ^1 A_P"OB7^=$7#V3DX*Z:77_,)*7M%'F>NO0[QF5$+L0%49
M)/85YSX3^*0\1^*VTF2RC@@D$AMI0Y+/MY (]U!/X5K?$[6O[&\$7FQL3W?^
MBQXZ_-][_P =#5P'B3PW-X.\-^%-<MDQ=V#K]JQU+,?, /L#N7\13H4H2C[V
M[T7W?TA5JDHR]W9:L]PKCO%GQ M?#M['I=I:2ZEJTN-MK"?NYZ;B >3Z ?E7
M56=W%?V,%Y VZ&>-9$/JI&17EGPN1-4\:>*-7NP'O$EVH6Y*!F?./P4#Z5E2
MA&TI37P]#2I-WC&/4T&\7?$*!/M$W@R-H.NR.0E\?0$G]*]&MY'EMHI)(_+=
MT#,F<[21R*R_$WB.V\+:,VIW<4LL2NJ;8@-V3]2*T;&[2_T^VO(U94N(EE4-
MU 8 C/YTJCYHJ2C9#@K-IRN><CXA>)KW7M5TW1_#<-Z+"=XF83;3@,5!.<==
MIKL?#&HZWJ5G-)KFDKILZR;8XQ)OW+@<_GFO+/#VK:YI7CCQ:VBZ(=4:2\<2
MCS-GE@2/CZYR?RKU;PUJ6K:GITDVL:2=,N%E*K#YF_<N =V?J2/PK;$045I%
M=.NNW:YE0FY/5OKZ'+^/?B)<^#M8M;.'3X;E)H1*S.Y4CYB,#'TKL]-U6VU;
M1H-3LVWP31>8GM['W!X/TKS7Q[80:K\5?#]A<KN@N+1HGQUP?,&1[CK57P#J
M=SX2\2W_ (*U5\)([&U<]-^.,>S#!^ON:<J,944X_%:_JA*K)56I;7L=OX!\
M6S^,-'N+V>UCMVBN#"%C8D$;5.>?K4?B_P 83^&]9T.QAM(YEU*;RW9V(*?,
M@R/^^OTK!^"/_(JW_P#U_'_T!*A^*?\ R-O@W_K[/_HR*CV4/K+A;37\A^TE
M[!2OKI^9ZF2 ,D\"O.+SXF7FH:K-I_A+0Y-5,!P]P6Q'^'MZ$D9KJ/&]U+9^
M"-9GA)$@M7 (ZC(QG]:P_A#:00> ;>:-0)+B61Y6[DABH_1165.,53=22OK8
MN<I.:A%VZFGX3UOQ%JD]U#KVA?V:8E4QN&)63.<@=>F/7O74445C.2D[I6-8
MII6;N%%%%24%07EG;W]L]M=0K+"_56%3T4FDU9@<=+\-]'>;>D]W&F?N!U('
MXD9KH=)T2PT6 Q64 3=]YR<LWU-:%%9PH4H.\8V9"IQB[I''_%"UN+WP%?06
ML$L\S/%B.)"S'#KV%:WA"&2W\':/%+$T4J6<2NCKA@0HX(]:T+_4;73+<3WD
MOE1%@N[:3S^'TJ+3=9T_5_,^PW F\O&["D8SG'4>QK=UURJEUO<7*E4YKZV+
M]>2>&/"QU;7/&]EJMC/%:WDY,4KQ%>?,D(9"1R1D'_\ 77JEY>6]A:275U((
MX8\;F()QDX[?6DDOK:&ZM[9Y0)KC=Y2X/S8&3^E.%?V::76WYA.$9-7Z?KH>
M??#ZYUO0=0N/">LVER\$#'['>")C&1UV[L8P1R/3D>E:'Q+\(W?B33;6[TO_
M )"5@Y>)<X+J<9 /KD C\:[FLQ?$&EOJ)T];H&Z#F,Q[&^\.V<8JI8GEJ*IH
MG^?_  Y/LXJ'))Z' 0?$SQ%%:K9W/@V_DU11MRJ.$=O[V-N1]!^=:7@#PIJ=
MKJ=]XF\0X&JWV0(A_P LE)!.?0\ 8[ 5Z!66?$>D"_-BUZBW D\LJRD#=Z9Q
MC-.>)A&+22C?^K:B5.S3G*]MA?$4;R^&-6CC1GD>SF5549+$H< "N<^%-I<V
M/@>&&[MY;>43R$I*A5L9]#7;54O=2L]/:!;N=8C._EQ@Y^9JCVO+3<7M>YHX
MKG4V]CSOQOI-YXO\?:3HC6]VFDVR&2>X5"%R1DX8C&<!0/<FI-1^#NCMIMS]
MEO-2:Y$;&$2SJRE\?+D;>F<5Z75'4=7L=)6,WL_E"0D)\I;..O05H\7*$59V
M2,W1AK*>MSE?A7<7Y\(K8:E:7-O-92&-!/$R%HSRN,CG&2/P%<]JNA>(?!'C
M&Z\1>'K)M0T^\):XM4!+#)R1@<]>00#CH??U.TN[>^MDN+69987^ZZG@U%J&
MIV>E0+->S"*-FV E2<GKCCZ&E]92E*II9[]@=)<B3>W4\B\6>*]6\::%_8]I
MX2U.*9Y5=F*,P7!Z?='ZXKUG0X)+;0--MYD*2Q6L2.I[,% (J>RO;?4+5;FU
MD\R%B0&P1G!P>M+<WEO9^3]HD">=((H\@G<QZ"E4KQE!**LM]^XX0Y6YMWN>
M.:3JVK^$?&7B:Y7PSJ-]'>W;[&CC=1@2.<@[3D'=7IGA7Q#<^(K*>XNM'N=,
M:.38([C.7& <C(''.*UQ>VYOFLA(/M*QB4I@_=SC/YT^XN(K6WDGF;;%&I9F
MQG %.K7A45[:][]@ITW#[6AY[XFL+R;XN^&KN*TG>VBBQ),L9*)R_4]!U%.^
M*?A2?5;"#6]+C<ZI8$$"(9=TSGC'4J>1^-=A8^(])U*Y%M:78EE()VA&'3KU
M%:;,%4L3@ 9-*&*UC*'V=!>RC)25]SSOX.6-Y8>&;Z.]M9[:1KPL%FC*$C8O
M.#4/Q+T^]O/%/A*6VM)YXX;G,C11E@@WQ\DCIT/Y5Z+:7<%]:QW-M()(9!E6
M (R/QIMY>VVGVS7%W.D,2]6<T_K/[QUN_P#D'LE[)0OH-U.PBU72[K3Y\^5<
MQ-$V.H!&,UY'HE[XK^&C7&E7.A3ZIIID+Q2VX8@$]P0#@''W3BO6]/U*TU6W
M,]E-YL8;:3M(P?3D>XJ2\O+:PMGN;N98H4ZLU32KJ,'>SB_ZW*G!2M-.S74Y
MWPGXHU+Q)/<FZ\/W.F6T2J8WGSF0DG(&5'2NIJM8:A;:E;^?:2%X]Q7)4KS]
M"!5FH<HS?-%61<$TM7<****104444 %%%% $5SS:S?[A_E65X24KX5T\$$'R
MN0?J:VJ*CE]_F%;6Y@^,U+>$K\*"20G _P!]:S6LK^V\5:"UWJ#WJD3;<PJG
ME_)[>O\ 2NPHK.=%3ES7[?@[DRA=W"N*T>Y,/B?4(&U%X?,OY"+7[/N$O'7?
MCC\^U=K15U*?,TT]ARC=IA7F\D<O]M71O"XTAM6)EV*,K( "I)QG:>AQ7I%%
M36I>TMKL*<.:P5PGB2VN]=UF[AMK)[B*SM_*1A($V2MAMPSUX '%=W13JTO:
MQY6]!SCS*QG:%?G4M$M+IP1(Z 2 C&&'!_4&LGQ1'=2:OH0LV1)O.DVNZEE7
MY>X%=/11*FY0Y6^WX XWC9F=H>E#1].%MYIE<NTDC[=H+$Y.!V%9/C9BEGIL
M@E:'9?QL953?Y> WS8[XKIZ*)4DZ?LUH#C>/*BAHUP+G2XI1>->9+#SFB\LM
MR?X<#'I6=XM)CM=.NMCM%;7\4TI5<E4&<G ^M=!13E#FAR7!QO&QS.EW,>J>
M+KK4;3<]HMFD'FE2H9]Q; SUXKIJ**=.'*M0BK'/^&5*W6N94C.HR$9'7@5N
M3_\ 'O+_ +A_E4E%$(<L>7^NH15E8Q/""E?">G!@01&>#]353Q8#%<Z1>RQ/
M+96UP6G55W;<CY6(]N:Z:BI=*]-0OV_ 7)[O*4].U*TU2!I[)R\8;:6*%><#
MU ]:I>)X;*;1R+^Y>VC61629%)*..AP!6S15.+E#E8VKJS,+PM?7M_ITSWC>
M:$F9(;CR_+\Y!T;;6[113A%QBDW<<596"BBBJ&%%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
%%% '_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
